Discontinuation report CARBOLITH
Report ID | 247352 |
Drug Identification Number | 00236683 |
Brand name | CARBOLITH |
Common or Proper name | CARBOLITH |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LITHIUM CARBONATE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 1000's |
ATC code | N05AN |
ATC description | ANTIPSYCHOTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-10-18 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2025-01-09 | French | Compare |
v1 | 2025-01-09 | English | Compare |
Showing 1 to 2 of 2